Patents by Inventor Tanya A. Camacho-Villegas

Tanya A. Camacho-Villegas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polynucleotides encoding VNAR anti-cytokine domains
    Patent number: 9683035
    Abstract: The present invention concerns therapeutic compositions containing proteins that are the variable regions of IgNAR immunoglobulins, denominated vNAR, that specifically bind and neutralizes cytokines involved in a diversity of process such as inflammation and neovascularization, its ability to reach, bind, and neutralize the activity of one antigenic molecule localized in an immunoprivileged organs, are also described.
    Type: Grant
    Filed: July 25, 2016
    Date of Patent: June 20, 2017
    Assignee: LABORATORIOS SILANES, S.A. DE C.V.
    Inventors: Jorge F. Paniagua-Solís, María Teresa Mata-González, Walter J. García-Ubbelohde, Araceli Olguín-Jimenez, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas, Edna Sanchez-Castrejon
  • VHNAR ANTI-CYTOKINE DOMAINS
    Publication number: 20170037122
    Abstract: The present invention concerns therapeutic compositions containing proteins that are the variable regions of IgNAR immunoglobulins, denominated vNAR, that specifically bind and neutralizes cytokines involved in a diversity of process such as inflammation and neovascularization, its ability to reach, bind, and neutralize the activity of one antigenic molecule localized in an immunoprivileged organs, are also described.
    Type: Application
    Filed: July 25, 2016
    Publication date: February 9, 2017
    Inventors: Jorge F. Paniagua-Solís, María Teresa Mata-González, Walter J. García-Ubbelohde, Araceli Olguín-Jimenez, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas, Edna Sanchez-Castrejon
  • VNAR anti-cytokine domains
    Patent number: 9399677
    Abstract: The present invention concerns therapeutic compositions containing proteins that are the variable regions of IgNAR immunoglobulins, denominated vNAR, that specifically bind and neutralizes cytokines involved in a diversity of process such as inflammation and neovascularization, its ability to reach, bind, and neutralize the activity of one antigenic molecule localized in an immunoprivileged organs, are also described.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: July 26, 2016
    Assignee: LABORATORIES SILANES S.A. DE C.V.
    Inventors: Jorge F. Paniagua-Solís, María Teresa Mata-González, Walter J. García-Ubbelohde, Araceli Olguín-Jimenez, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas, Edna Sanchez-Castrejon
  • VHNAR ANTI-CYTOKINE DOMAINS
    Publication number: 20140044716
    Abstract: The present invention concerns therapeutic compositions containing proteins that are the variable regions of IgNAR immunoglobulins, denominated vNAR, that specifically bind and neutralizes cytokines involved in a diversity of process such as inflammation and neovascularization, its ability to reach, bind, and neutralize the activity of one antigenic molecule localized in an immunoprivileged organs, are also described.
    Type: Application
    Filed: July 17, 2013
    Publication date: February 13, 2014
    Applicant: LABORATORIOS SILANES, S.A. DE C.V.
    Inventors: Jorge F. Paniagua-Solís, María Teresa Mata-González, Walter J. García-Ubbelohde, Araceli Olguín-Jimenez, Alexei F. Lícea-Navarro, Tanya A. Camacho-Villegas, Edna Sanchez-Castrejon
  • VNAR anti-cytokine domains
    Patent number: 8496933
    Abstract: The present invention concerns therapeutic compositions containing proteins that are the variable regions of IgNAR immunoglobulins, denominated vNAR, that specifically bind and neutralizes cytokines involved in a diversity of process such as inflammation and neovascularization, its ability to reach, bind, and neutralize the activity of one antigenic molecule localized in an immunoprivileged organs, are also described.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: July 30, 2013
    Assignee: Laboratorios Silanes, S.A. de C.V.
    Inventors: Jorge F. Paniagua-Solís, María Teresa Mata-González, Walter J. García-Ubbelohde, Araceli Olguín-Jimenez, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas, Edna Sanchez-Castrejon
  • VHNAR ANTI-CYTOKINE DOMAINS
    Publication number: 20110129473
    Abstract: The present invention concerns therapeutic compositions containing proteins that are the variable regions of IgNAR immunoglobulins, denominated vNAR, that specifically bind and neutralizes cytokines involved in a diversity of process such as inflammation and neovascularization, its ability to reach, bind, and neutralize the activity of one antigenic molecule localized in an immunoprivileged organs, are also described.
    Type: Application
    Filed: November 4, 2010
    Publication date: June 2, 2011
    Applicant: Laboratorios Silanes, S.A. de C.V.
    Inventors: JORGE F. PANIAGUA-SOLÍS, María Teresa MATA-GONZÁLEZ, Walter J. GARCÍA-UBBELOHDE, Araceli OLGUÍN-JIMENEZ, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas, Edna Sanchez-Castrejon